Adverse event identification and management in locally advanced/metastatic urothelial carcinoma
touchPANEL DISCUSSION for touchONCOLOGY
Listen to an oncologist, urologist and nurse discuss adverse event identification and management with immunotherapies and targeted therapies for locally advanced or metastatic urothelial carcinoma.
The experts:
This touchPODCAST is for HCPs outside the US only.
This activity is funded by an independent medical education grant from Astellas Inc. and Seagen Inc., and is jointly provided by USF Health and touchIME.
For further information please visit: https://touchoncologyime.org/adverse-event-identification-and-management-in-locally-advanced-metastatic-urothelial-carcinoma
Create your
podcast in
minutes
It is Free